Experienced in Nasopharyngeal Carcinoma

Dr. Emma B. Holliday

Radiation Oncology
1840 Old Spanish Trl, 
Houston, TX 
Offers Telehealth
Experienced in Nasopharyngeal Carcinoma
1840 Old Spanish Trl, 
Houston, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Emma Holliday is a Radiation Oncologist in Houston, Texas. Dr. Holliday is rated as an Experienced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. Her top areas of expertise are Anal Cancer, Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), and Stomach Cancer.

Her clinical research consists of co-authoring 159 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 3 articles in the study of Nasopharyngeal Carcinoma.

Specialties
Radiation Oncology
Licenses
Radiology in TX
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

MD Anderson
1840 Old Spanish Trl, Houston, TX 77054
Other Locations
MD Anderson
2130 W Holcombe Blvd, Univ Of Tx M D Ande Life, Houston, TX 77030
MD Anderson
2240 Gulf Fwy S, Utmb Health League City Ho, League City, TX 77573

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Single-arm Phase 2 Study to Examine Pembrolizumab and Concurrent Radiation to Induce an Abscopal Effect in Patients With Previously Treated Carcinoma of Unknown Primary (CUP16-268)
Single-arm Phase 2 Study to Examine Pembrolizumab and Concurrent Radiation to Induce an Abscopal Effect in Patients With Previously Treated Carcinoma of Unknown Primary (CUP16-268)
Enrollment Status: Terminated
Publish Date: April 18, 2024
Intervention Type: Radiation, Drug
Study Phase: Phase 2
Linear Energy Transfer (LET)-Optimized Intensity Modulated Proton Therapy (IMPT) as a Component of Definitive Chemoradiation for Newly Diagnosed Squamous Cell Carcinoma of the Anal Canal: a Feasibility Trial
Linear Energy Transfer (LET)-Optimized Intensity Modulated Proton Therapy (IMPT) as a Component of Definitive Chemoradiation for Newly Diagnosed Squamous Cell Carcinoma of the Anal Canal: a Feasibility Trial
Enrollment Status: Completed
Publish Date: June 29, 2023
Intervention Type: Drug, Procedure, Other, Radiation
Study Drugs: Cisplatin, Fluorouracil
Study Phase: Phase 2
A Multicenter Study With an Open-label Phase Ib Part Followed by a Randomized, Placebo-controlled, Double-blind, Phase II Part to Evaluate Efficacy, Safety, Tolerability, and Pharmacokinetics of the DNA-PK Inhibitor Peposertib (M3814) in Combination With Capecitabine and RT in Participants With Locally Advanced Rectal Cancer
A Multicenter Study With an Open-label Phase Ib Part Followed by a Randomized, Placebo-controlled, Double-blind, Phase II Part to Evaluate Efficacy, Safety, Tolerability, and Pharmacokinetics of the DNA-PK Inhibitor Peposertib (M3814) in Combination With Capecitabine and RT in Participants With Locally Advanced Rectal Cancer
Enrollment Status: Completed
Publish Date: March 21, 2023
Intervention Type: Drug, Radiation
Study Phase: Phase 1/Phase 2
View 2 Less Clinical Trials

159 Total Publications

Measurable imaging-based changes in enhancement of intrahepatic cholangiocarcinoma after radiotherapy reflect physical mechanisms of response.
Measurable imaging-based changes in enhancement of intrahepatic cholangiocarcinoma after radiotherapy reflect physical mechanisms of response.
Journal: NPJ systems biology and applications
Published: July 15, 2025
Similar Doctors
Distinguished in Nasopharyngeal Carcinoma
Dr. Adam S. Garden
Radiation Oncology
Distinguished in Nasopharyngeal Carcinoma
Dr. Adam S. Garden
Radiation Oncology

MD Anderson

2130 W Holcombe Blvd, Univ Of Tx M D Ande Life, 
Houston, TX 
 (0.9 miles away)
713-592-5433
Languages Spoken:
English
See accepted insurances

Adam Garden is a Radiation Oncologist in Houston, Texas. Dr. Garden is rated as a Distinguished provider by MediFind in the treatment of Nasopharyngeal Carcinoma. His top areas of expertise are Adenoid Cystic Carcinoma, Throat Cancer, Laryngeal Cancer, Nasopharyngeal Carcinoma, and Gastrostomy.

Advanced in Nasopharyngeal Carcinoma
Dr. Jack P. Phan
Radiology | Radiation Oncology
Advanced in Nasopharyngeal Carcinoma
Dr. Jack P. Phan
Radiology | Radiation Oncology

MD Anderson

2130 W Holcombe Blvd, Univ Of Tx M D Ande Life, 
Houston, TX 
 (0.9 miles away)
713-592-5433
Languages Spoken:
English
See accepted insurances

Jack Phan is a Radiologist and a Radiation Oncologist in Houston, Texas. Dr. Phan is rated as a Distinguished provider by MediFind in the treatment of Nasopharyngeal Carcinoma. His top areas of expertise are Olfactory Neuroblastoma, Adenoid Cystic Carcinoma, Throat Cancer, Laryngeal Cancer, and Gastrostomy.

Advanced in Nasopharyngeal Carcinoma
Dr. Angel I. Blanco
Radiation Oncology
Advanced in Nasopharyngeal Carcinoma
Dr. Angel I. Blanco
Radiation Oncology

Oncology Consultants, P. A.

10405 Katy Fwy, Suite 120, 
Houston, TX 
 (11.1 miles away)
713-722-9660
Languages Spoken:
English, Louisiana Creole French, Spanish
See accepted insurances
Accepting New Patients

Angel Blanco is a Radiation Oncologist in Houston, Texas. Dr. Blanco is rated as a Distinguished provider by MediFind in the treatment of Nasopharyngeal Carcinoma. His top areas of expertise are Metastatic Brain Tumor, Radiation Induced Meningioma, Meningioma, and Astrocytoma. Dr. Blanco is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Holliday's expertise for a condition
ConditionClose
View All 14 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile